Key facts
- This page summarizes BAUPOST GROUP LLC/MA's Form 4/A - Amendment filing for Translate Bio, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Sep 2021, 17:43.
BAUPOST GROUP LLC/MA - 14 Sep 2021 Form 4/A - Amendment Insider Report for Translate Bio, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 14 Sep 2021
- Net transaction value
- -$685,681,082
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 16 Sep 2021, 17:43:14 UTC
- Original report date
- 30 Jun 2020
- Prior SEC filing
- 13 May 2021
- Next SEC filing
- 14 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- Seth A. Klarman
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
BAUPOST GROUP LLC/MA filed Form 4/A - Amendment for Translate Bio, Inc. on 16 Sep 2021.
Change
- Previous filing in this sequence was filed on 13 May 2021.
- Current net transaction value: -$685,681,082.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBIO
transaction
Common Stock
Other
- Transaction value
- $685,681,082
- Shares
- -18,044,239
- Change %
- -100%
- Price
- $38.00
- Shares after
- 0
- Date
- 14 Sep 2021
- Ownership
- See footnote 1 and 2
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.
Footnote F2
(Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.
Footnote F3
On September 14, 2021, the Agreement and Plan of Merger among Sanofi, Vector Merger Sub Inc. and Translate Bio Inc. ("Merger Agreement") was consummated and Sanofi completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on September 14, 2021, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $38.00 per share.